Evidence map›Paper›PMID 33615057›Full record

ArticleKidney international reports2021

Catheter Diversion Procedure With Exit-Site Renewal Promotes Peritoneal Dialysis Catheter Survival.

Rikako Oki, Yoshifumi Hamasaki, Yohei Komaru, Yoshihisa Miyamoto, Ryo Matsuura, Daisuke Yamada, Masao Iwagami, Kent Doi, Haruki Kume, Masaomi Nangaku

Open access · goldAbstract read
In one paragraph

Article in Kidney international reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Rikako OkiDepartment of Hemodialysis and Apheresis, University of Tokyo Hospital, Tokyo, Japan.
Yoshifumi HamasakiDepartment of Hemodialysis and Apheresis, University of Tokyo Hospital, Tokyo, Japan.
Yohei KomaruDepartment of Hemodialysis and Apheresis, University of Tokyo Hospital, Tokyo, Japan.
Yoshihisa MiyamotoDepartment of Hemodialysis and Apheresis, University of Tokyo Hospital, Tokyo, Japan.
Ryo MatsuuraDepartment of Hemodialysis and Apheresis, University of Tokyo Hospital, Tokyo, Japan.
Daisuke YamadaDepartment of Urology, University of Tokyo Hospital, Tokyo, Japan.
Masao IwagamiDepartment of Health Services Research, Faculty of Medicine, University of Tsukuba, Tokyo, Japan.
Kent DoiDepartment of Acute Medicine, University of Tokyo Hospital, Tokyo, Japan.
Haruki KumeDepartment of Urology, University of Tokyo Hospital, Tokyo, Japan.
Masaomi NangakuDepartment of Hemodialysis and Apheresis, University of Tokyo Hospital, Tokyo, Japan.
University of Tokyo Hospital · JPUniversity of Tsukuba · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCatheter-related infections such as exit site infection (ESI) and tunnel infection (TI) are major causes of peritoneal dialysis (PD) discontinuation. For ESI/TI treatment, catheter diversion procedure (CDP) with exit-site renewal for catheter salvage presents an alternative to catheter removal. Nevertheless, CDP capability of improving PD catheter survival remains unclear.

methodsWe retrospectively reviewed our hospital patients who started PD during 2001-2019 (

resultsFor patients (76% male, mean age of 61.7±13.0 years), 40 CDP were performed for 33 CDP group patients. Infection-free rates at 30 and 90 days after CDP were, respectively, 90% and 67%. The CDP group PD catheter survival rate was significantly higher than that of virtual discontinuation group (

conclusionResults show that CDP may improve PD catheter survival as an effective and less-invasive surgical treatment for ESI/TI to avoid withdrawal of PD.

Indexed as

catheter diversion procedureexit site infectionperitoneal dialysistunnel infection

Identifiers

PMID33615057
PMCPMC7879110
OpenAlexW3112195099

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.